• NEBANNER

Manufacturing Companies for Human Vascular System - 3-Amino-4-pyrazole carbosamide hemisulfate – JIN DUN

Manufacturing Companies for Human Vascular System - 3-Amino-4-pyrazole carbosamide hemisulfate – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We stick to our enterprise spirit of "Quality, Performance, Innovation and Integrity". We purpose to create a lot more price for our prospects with our rich resources, innovative machinery, experienced workers and great products and services for Anionic Polyacrylamide, Cyclohexyl Methacrylate, Polyvinylpyrrolidone K30, Our products enjoy good popularity among our customers. We welcome customers, business associations and friends from all parts of the world to contact us and seek cooperation for mutual benefits.
Manufacturing Companies for Human Vascular System - 3-Amino-4-pyrazole carbosamide hemisulfate – JIN DUN Detail:

Intermediate for the synthesis of allopurinol.

It is one of the 3-amino-4-substituted pyrazole series. It can be used as an intermediate to synthesize many pharmacologically effective organic compounds, such as allopurinol, one of the pyrazolopyrimidine derivatives series, the latter since 1963 Since its clinical use, it has been the main drug for the treatment of gout. At present, there are few known methods for synthesizing

3-aminopyrazole-4-carboxamide hemisulfate in China, mainly by reacting malononitrile and triethyl orthoformate to prepare ethoxymethylene malononitrile, and then with The reaction of hydrazine hydrate yields 3-amino-4-cyanopyrazole, which is finally reacted with concentrated sulfuric acid to produce

3-aminopyrazole-4-carboxamide hemisulfate (Chen Huiru, Xiao Guomin et al. 3-aminopyrazole- Synthesis of 4-formamide hemisulfate [J]. Chemical Industry Times, 2008, 6 (22): 39 40), the total yield of synthesis by this method is about 60% (calculated as malononitrile), this method It involves a three-step reaction, the steps are longer, and the reagents used, such as malononitrile and ethoxymethylene malononitrile, are more toxic and expensive. In addition, the 3-aminopyrazole-4 prepared by this method -Formamide hemisulfate has a color that is difficult to remove and requires additional processing, which is more complicated.

There are reports in foreign literature using pyridylamide hydrazone and ethoxymethylene malononitrile as raw materials to obtain 3-amino-4-cyanopyrazole by addition and cyclization, and then react with concentrated sulfuric acid to obtain the target compound (Reuken G Jones. Reactions of orthoesters with activemethylene compounds[J]. J Am Chem Soc. 1952,74(5) :4889 4891). The main raw materials used in this method are expensive, the reaction yield is not high, and the profit of industrial production is low. It must be difficult.

Executive standard: Enterprise Standard
Exterior: Off-white or yellow powder

Package: 25kg/drum
assay(HPLC)content Greater than or equal to 98.0%
purity(HPLC)content Greater than or equal to 99.5%


Product detail pictures:

Manufacturing Companies for Human Vascular System - 3-Amino-4-pyrazole carbosamide hemisulfate – JIN DUN detail pictures


Related Product Guide:

The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme for Manufacturing Companies for Human Vascular System - 3-Amino-4-pyrazole carbosamide hemisulfate – JIN DUN , The product will supply to all over the world, such as: Sydney, Manchester, Nigeria, We will continue to devote ourselves to market & product development and build a well-knit service to our customer to create a more prosperous future. Please contact us today to find out how we can work together.
  • Perfect services, quality products and competitive prices, we have work many times, every time is delighted, wish continue to maintain!
    5 Stars By Matthew Tobias from Holland - 2018.09.23 18:44
    After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
    5 Stars By Gwendolyn from Marseille - 2018.09.29 17:23
    Write your message here and send it to us